Home > Qtrly Results > PIRAMAL PHARMA

PIRAMAL PHARMA
Quarterly Results Analysis [Mar2025]

PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹2,754 Cr ₹2,204 Cr ₹2,242 Cr ₹1,951 Cr ₹2,552 Cr ₹1,959 Cr ₹1,911 Cr ₹1,749 Cr
Expenses ₹2,193 Cr ₹1,866 Cr ₹1,900 Cr ₹1,747 Cr ₹2,022 Cr ₹1,690 Cr ₹1,646 Cr ₹1,617 Cr
Operating Income ₹561 Cr ₹338 Cr ₹342 Cr ₹204 Cr ₹530 Cr ₹268 Cr ₹266 Cr ₹132 Cr
Other Income ₹42 Cr ₹12 Cr ₹61 Cr ₹20 Cr ₹26 Cr ₹62 Cr ₹49 Cr ₹38 Cr
Interest ₹104 Cr ₹103 Cr ₹108 Cr ₹107 Cr ₹114 Cr ₹106 Cr ₹110 Cr ₹119 Cr
Depreciation ₹243 Cr ₹197 Cr ₹192 Cr ₹185 Cr ₹196 Cr ₹186 Cr ₹185 Cr ₹174 Cr
Profit Before Tax ₹257 Cr ₹50 Cr ₹103 Cr ₹-67 Cr ₹215 Cr ₹5 Cr ₹20 Cr ₹-122 Cr
Profit After Tax ₹137 Cr ₹-13 Cr ₹5 Cr ₹-111 Cr ₹89 Cr ₹-4 Cr ₹-14 Cr ₹-113 Cr
EPS ₹1.16 ₹0.03 ₹0.17 ₹-0.67 ₹0.77 ₹0.08 ₹0.04 ₹-0.81
Industry Peers & Returns1W1M1Y
PIRAMAL PHARMA 1.1% -2.7% 37.6%
SUN PHARMACEUTICAL INDUSTRIES -0.5% -8.4% 14.6%
DIVIS LABORATORIES -2.4% 7.2% 50.6%
CIPLA -0.7% -3.7% -1%
TORRENT PHARMACEUTICALS -1.4% -3.9% 19%
DR REDDYS LABORATORIES 0.5% 5.6% 5.1%
MANKIND PHARMA -1.6% 1.3% 17%
ZYDUS LIFESCIENCES 1.2% 4.9% -11.5%
LUPIN -0.5% -4.8% 22.1%

PIRAMAL PHARMA Quarterly Revenues

Revenues
Q-o-Q

24.95 %

Y-o-Y

7.90 %

Quarters Revenues % Change
Mar2025 ₹2,754 Cr
24.95
Dec2024 ₹2,204 Cr
-1.67
Sep2024 ₹2,242 Cr
14.89
Jun2024 ₹1,951 Cr
-23.56
Mar2024 ₹2,552 Cr
30.32
Dec2023 ₹1,959 Cr
2.47
Sep2023 ₹1,911 Cr
9.29
Jun2023 ₹1,749 Cr -

PIRAMAL PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

66.10 %

Y-o-Y

5.86 %

Quarters Operating Profit % Change
Mar2025 ₹561 Cr
66.10
Dec2024 ₹338 Cr
-1.13
Sep2024 ₹342 Cr
67.05
Jun2024 ₹204 Cr
-61.41
Mar2024 ₹530 Cr
97.46
Dec2023 ₹268 Cr
1.03
Sep2023 ₹266 Cr
100.76
Jun2023 ₹132 Cr -
Operating Margins
Q-o-Q

32.96 %

Y-o-Y

-1.88 %

Quarters Operating Margin% % Change
Mar2025 20.37%
32.96
Dec2024 15.32%
0.52
Sep2024 15.24%
45.42
Jun2024 10.48%
-49.52
Mar2024 20.76%
51.53
Dec2023 13.7%
-1.44
Sep2023 13.9%
83.62
Jun2023 7.57% -

PIRAMAL PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

53.85 %

Quarters Profit After Tax % Change
Mar2025 ₹137 Cr
Positive
Dec2024 ₹-13 Cr
Negative
Sep2024 ₹5 Cr
Positive
Jun2024 ₹-111 Cr
Negative
Mar2024 ₹89 Cr
Positive
Dec2023 ₹-4 Cr
Negative
Sep2023 ₹-14 Cr
Negative
Jun2023 ₹-113 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

42.29 %

Quarters PAT Margin(%) % Change
Mar2025 4.98 %
Positive
Dec2024 -0.61 %
Negative
Sep2024 0.24 %
Positive
Jun2024 -5.69 %
Negative
Mar2024 3.5 %
Positive
Dec2023 -0.2 %
Negative
Sep2023 -0.74 %
Negative
Jun2023 -6.46 % -

PIRAMAL PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

3,766.67 %

Y-o-Y

50.65 %

Quarters EPS % Change
Mar2025 ₹1.16
3,766.67
Dec2024 ₹0.03
-82.35
Sep2024 ₹0.17
Positive
Jun2024 ₹-0.67
Negative
Mar2024 ₹0.77
862.50
Dec2023 ₹0.08
100.00
Sep2023 ₹0.04
Positive
Jun2023 ₹-0.81 -

You may also like the below Video Courses